Date

Fact Sheets

Medicare Referring Provider Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Transparency Data (CY2013)

Medicare Referring Provider Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Transparency Data (CY2013)

The Centers for Medicare & Medicaid Services (CMS) released a new dataset, the Referring Provider Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Public Use File (Referring Provider DMEPOS PUF).  This data set, which is part of CMS’s Medicare Provider Utilization and Payment Data set, details information on DMEPOS products and services provided to Medicare beneficiaries via referrals through physicians and other healthcare professionals.  Some examples include wheelchairs, walkers, oxygen supplies, nebulizers, and diabetes testing supplies, as wells as other products such as enteral/parenteral nutrition, inhalation solutions, and certain chemotherapy drugs.  These new data include information on 385,915 referring providers, over 100 million claims, and $11 billion in Medicare allowed payments for 2013.  The data is posted on the CMS website at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/DME.html.

The data set identifies individual providers who referred DMEPOS specific services using their National Provider Identifier (NPI). These services have been furnished by suppliers of DMEPOS and have been identified using Healthcare Common Procedure Coding System (HCPCS) codes. For each referring provider and DMEPOS service, the data set has the total number of services that were furnished by DMEPOS suppliers, the supplier’s average charge, the average Medicare payment, and the average Medicare allowed amount, which is the sum of Medicare’s payment and any deductible or coinsurance owed by the beneficiary.  The data set does not contain any individually identifiable information about Medicare beneficiaries. To further protect the privacy of Medicare beneficiaries, any aggregated records which are derived from 10 or fewer claims are excluded from the Referring Provider DMEPOS PUF.

The Referring Provider DMEPOS PUF data allow for many types of analyses to be performed, including, for example, summary analyses by provider specialty. Table 1 below displays the patterns of DMEPOS utilization and Medicare allowed amounts for the ten largest referring provider specialties. Internal Medicine and Family Practice are the largest referring specialties with more than 80,000 unique providers in each specialty prescribing DMEPOS products. These providers refer an average of 36 and 38 DMEPOS products, respectively, and make referrals to a higher number of DMEPOS suppliers than most other common specialties. Conversely, Cardiology and Urology specialists refer fewer unique products and have fewer unique suppliers. Additionally, the data show that allowed amounts for referred DMEPOS products vary among these specialty types, from a low of $12K for Physician Assistants to a high of $156K for Pulmonary Disease specialists (likely due to the large amount of oxygen and nebulizer supplies prescribed by these specialists).

Table 1. Average DMEPOS Medicare Allowed Amounts and Number of Unique Products for Common Referring Provider Specialties, 2013.

Referring Provider Specialty Number of Referring Providers Average Number of Unique DMEPOS Suppliers Average Number of Unique DMEPOS Product Types Average DMEPOS Allowed Amount
Internal Medicine 87,107 25 36 $29,954
Family Practice 81,603 25 38 $27,982
Nurse Practitioner 34,577 12 18 $16,381
Physician Assistant 21,223 11 17 $12,285
Orthopedic Surgery 17,598 10 24 $23,238
General Surgery 10,699 7 19 $25,796
Cardiology 10,526 10 15 $38,929
Podiatry 9,656 6 18 $22,372
Pulmonary Disease 8,513 34 38 $156,021
Urology 7,975 9 15 $24,631

 

Chart 1 below shows another type of comparison that can be conducted using the new DMEPOS data. The left column represents DMEPOS utilization as measured by the number of claims and the right column reflects the Medicare allowed amount, both categorized by Berenson-Eggers Type of Service (BETOS) Classification Group (i.e., durable medical equipment; prosthetic and orthotic devices; and drugs and nutritional products).  Durable medical equipment claims accounted for 80% of all DMEPOS claims and 62% of the total Medicare allowed amount for DMEPOS services. Claims for prosthetic and orthotic devices, drugs and nutritional products accounted for a disproportionate share of the total allowed amount for DMEPOS services.  Prosthetic and orthotic devices accounted for 10% of claims but 20% of the total allowed amount, while drugs and nutritional products accounted for 9% of claims and 18% of allowed amounts.   

Chart 1. Distribution of DMEPOS Claims and Medicare Allowed Amount by Category, 2013.

Chart 1 shows the distribution of DMEPOS claims and associated Medicare allowed amounts by three BETOS classification groups including a) Drugs and Nutritional Products, b) Prosthetic and Orthotic Devices and c) Durable Medical Equipment. The data are presented in side by side stacked bar charts. Drugs and Nutritional Products accounted for 9% of DMEPOS claims and 18% of Medicare allowed amounts for DMEPOS services.  Prosthetic and Orthotic Devices accounted for 10% of DMEPOS claims and 20% of Medicare allowed amounts for DMEPOS services.  Durable Medical Equipment accounted for 80% of DMEPOS claims and 62% of DMEPOS Medicare allowed amounts for DMEPOS services.

The Referring Provider DMEPOS PUF files also can be used to examine how the referring of DMEPOS products varies across provider specialties.  Chart 2 below shows the distribution of claims categorized by BETOS Classification Group across common referring provider specialties.  Specialties such as internal medicine and pulmonary disease refer a higher percentage of durable medical equipment products than other specialties, while provider specialties such as urology and podiatry refer a higher percentage of prosthetics and orthotic devices.

Chart 2. Distribution of DMEPOS Claims by Category for Common Referring Provider Specialties, 2013.

Chart 2 shows stacked bar chart distribution of DMEPOS claims by three BETOS classification groups for six common referring provider specialty categories.  The three groups include Drugs and Nutritional Products, Prosthetic and Orthotic Devices and Durable Medical Equipment (DME). Within Internal Medicine, DME - 90% of DMEPOS claims, Drugs and Nutritional Products - 8% of claims and Prosthetic and Orthotic Devices - 2% of claims; Pulmonary Disease, DME - 92% of claims and Drugs and Nutritional Products - 8% of claims; Nephrology, DME - 16% of claims, Drugs and Nutritional Products - 84% of claims; General Surgery, DME - 26% of claims, Drugs and Nutritional Products - 51% of claims and Prosthetic and Orthotic Devices - 22% of claims; Urology, DME - 2% of claims, Drugs and Nutritional Products - 4% of claims and Prosthetic and Orthotic Devices - 93% of claims; and Podiatry, DME - 17% of claims and Prosthetic and Orthotic Devices - 83% of claims.

The Referring Provider DMEPOS PUF data file can also be used to examine the referring of specific DMEPOS services by provider specialty. Chart 3 below shows the Medicare allowed amount overall and for the top HCPCS codes across common referring provider specialties. For both Internal Medicine and Pulmonary Disease, oxygen concentrators were the top referred service, accounting for approximately 25% of each specialty’s total Medicare allowed amount. For Urology, urinary catheters accounted for 40% of the total Medicare allowed amount for DMEPOS services.

Chart 3. DMEPOS Medicare Allowed Amount Overall and for the Top HCPCS by Referring Provider Specialty, 2013.

Chart 3 shows a stacked bar chart distribution of DMEPOS Medicare allowed amount both overall and by top HCPCS for six common referring provider specialty categories.  Within Internal Medicine, the overall DMEPOS Medicare allowed amount is $1,630,324,083 and the top HCPCS (Oxygen Concentrator E1390) Medicare allowed amount is $392,594,946; for Pulmonary Disease, the amount is $1,198,194,832 and $278,146,589, respectively. Within Nephrology, the overall DMEPOS Medicare allowed amount is $255,687,459 and the Medicare allowed amount for the top HCPCS (Tacrolimus – J7507) is $73,008,262; General Surgery, the overall DMEPOS Medicare allowed amount is $145,580,833 and the Medicare allowed amount for the top HCPCS (Mycophenolic Acid – J7518) is $22,690,455; Urology, the overall DMEPOS Medicare allowed amount is $142,170,509 and the Medicare allowed amount for the top HCPCS (Urinary Catheter – A4351) is $56,167,669.

Chart 4 below shows, for the ten largest referring provider specialties, the relationship between the average Medicare allowed amount per referred DMEPOS claim (y-axis) and the total Medicare allowed amount that those DMEPOS referrals contributed to the Medicare program (x-axis) in 2013.  Also, the numbers of providers in that specialty are represented by bubble size.  Internal Medicine and Family Practice physicians comprise the largest specialties who referred DMEPOS products. The DMEPOS referred by these providers have large total allowed amounts in the Medicare program, but their average allowed amount per referred claim is low compared to some other specialties. Conversely, Hematology/Oncology, Cardiology, and General Surgery professionals comprised much smaller groups of providers and referred lower total allowed amounts, but have higher average allowed amounts per DMEPOS claim than Family Practice and Internal Medicine.

Chart 4. Average DMEPOS Medicare Allowed Amount per Claim versus Total Allowed Amount for Selected Top Specialties, 2013.

Chart 4 displays a bubble chart showing the relationship between average Medicare allowed amount per referred DMEPOS claim and the total Medicare allowed amount that the DMEPOS referrals contributed to the Medicare program, by specialty size.  It shows that Internal Medicine is a large group with $2.6B in total costs and $148 average per claim. Family Practice is a large group with $2.3B in total costs and $143 average per claim. Pulmonary Disease is a small group with $1.3B in total costs and $187 average per claim. Nurse Practitioner is a medium group with $566M in total costs and $166 average per claim. Cardiology is a small group with $410M in total costs and $440 average per claim. Orthopedic Surgery is a small group with $409M in total costs and $325 average per claim. Hematology/Oncology is a small group with $290M in total costs and $573 average per claim. General Surgery is a small group with $276M in total costs and $446 average per claim.

The DMEPOS data can be used for geographic comparisons of costs and utilization of DMEPOS services/products and when combined with data on the number of beneficiaries enrolled in Medicare Part B coverage, per capita averages can be calculated.  Map 1 below displays the per capita Medicare allowed amounts for all DMEPOS products by state for 2013.  Nationally, the per capita allowed amount for all DMEPOS was $343.70 per enrolled beneficiary.  As the map demonstrates, states with the highest allowed amount rates were in the South and Midwest, and states with the lowest rates were in the West and Northeast.

Map 1.  Per Capita DMEPOS Medicare Allowed Amount by State, 2013.

Map 1 illustrates the geographic variation in per capita DMEPOS Medicare allowed amounts across states. States with the highest per capita DMEPOS Medicare allowed amounts are located predominantly in southeastern states (eg, Kentucky, Tennessee, North Carolina) as well as Utah, Colorado and Minnesota. Counties with the lowest per capita DMEPOS Medicare allowed amounts are found mostly in northwestern and northeastern states (eg, Washington, Montana, Vermont, New Hampshire).


###